Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CREARE LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- JDKYAKDT4TT6
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Magnetic resonance histology to image the brains of small animals
is a critical technology for biology, toxicology, and drug discovery research.
To achieve high-resolution, the radio frequency (RF) probes used to obtain the
images must have a very high signal-to-noise ratio. We propose an innovative RF
probe fabricated from high-temperature superconducting material. The probe
achieves high signal-to-noise ratio through the use of superconducting coil
elements. The novel cryogenic design enables precise control of the coil's
temperature. The probe design provides a solenoid coil surrounding the sample
for excellent coupling to the primary magnetic field, cryogenic cooling
distributed uniformly throughout the coil, and superinsulation that enables the
coil to be located very close to the sample. The probe design can accommodate
samples up to 2 cm in diameter, enabling MR histology of both mouse and rat
brains. In Phase I, we will prove the feasibility of the superconducting RF
coil by: (1) fabricating a prototypical coil element, and (2) demonstrating the
element's performance under prototypical, cryogenic conditions.
PROPOSED COMMERCIAL APPLICATION:
The key application for the RF probe is MR histology of small animal specimens. MR histology
(MRH) promises enormous benefits because it is extremely fast, allows use of unique
"proton stains," produces three-dimensional images of tissues, and produces digital images
that are easily shared. MRH has enormous screening potential because tissues can be
excised and scanned immediately. As a result, the RF probe developed in this program
will enable tremendous cost savings in the fields of drug discovery, toxicology, and the
study of fundamental physiology and disease mechanisms. Customers for the probe will
include pharmaceutical companies, research laboratories, and MR pathology service
providers.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
1,365 SBIR/STTR records share this UEI (1983–2026). Reported award amounts total $507,020,394. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Health and Human Services, Department of Energy, Department of Transportation, Department of Commerce
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards